Total Payments
$2,977
2024 Payments
$722.01
Companies
32
Transactions
165
Medicare Patients
4,468
Medicare Billing
$388,999
Payment Breakdown by Category
Food & Beverage$2,715 (91.2%)
Education$261.38 (8.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,715 | 161 | 91.2% |
| Education | $261.38 | 4 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $559.65 | 37 | $0 (2024) |
| Astellas Pharma US Inc | $442.35 | 31 | $0 (2024) |
| PFIZER INC. | $249.71 | 15 | $0 (2024) |
| COLOPLAST CORP | $204.95 | 15 | $0 (2024) |
| NeoTract Inc. | $198.67 | 4 | $0 (2019) |
| Avadel Specialty Pharmaceuticals, LLC | $187.00 | 4 | $0 (2018) |
| ABBVIE INC. | $160.38 | 11 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $154.21 | 8 | $0 (2024) |
| 180 Medical, Inc. | $130.94 | 6 | $0 (2024) |
| Allergan Inc. | $90.37 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $722.01 | 40 | Janssen Biotech, Inc. ($150.83) |
| 2023 | $338.90 | 19 | Sumitomo Pharma America, Inc. ($81.16) |
| 2022 | $83.78 | 5 | ABBVIE INC. ($19.15) |
| 2021 | $88.86 | 5 | Astellas Pharma US Inc ($29.29) |
| 2020 | $219.16 | 15 | Astellas Pharma US Inc ($69.74) |
| 2019 | $606.10 | 42 | Janssen Biotech, Inc. ($209.34) |
| 2018 | $778.22 | 30 | Avadel Specialty Pharmaceuticals, LLC ($187.00) |
| 2017 | $139.78 | 9 | Astellas Pharma US Inc ($58.49) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $23.38 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Urology | ||||||
| 10/16/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Urology | ||||||
| 10/08/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Urology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Oncology | ||||||
| 08/21/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $24.32 | General |
| 08/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/07/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Oncology | ||||||
| 07/24/2024 | Becton, Dickinson and Company | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Urology | ||||||
| 07/23/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $27.14 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 07/17/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $19.65 | General |
| 06/27/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: UROLOGY | ||||||
| 06/25/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $37.36 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: Oncology | ||||||
| 06/20/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $25.55 | General |
| 06/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 939 | 1,160 | $261,159 | $81,387 |
| 2022 | 17 | 1,077 | 1,328 | $289,809 | $93,452 |
| 2021 | 25 | 1,299 | 1,642 | $405,623 | $122,299 |
| 2020 | 21 | 1,153 | 1,361 | $338,958 | $91,861 |
Total Patients
4,468
Total Services
5,491
Medicare Billing
$388,999
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 126 | 144 | $75,744 | $20,952 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 189 | $30,240 | $17,971 | 59.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 125 | $15,000 | $8,199 | 54.7% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Office | 2023 | 12 | 13 | $31,252 | $7,062 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $13,000 | $5,271 | 40.5% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 18 | 18 | $13,698 | $4,773 | 34.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 23 | 23 | $14,007 | $3,935 | 28.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 16 | 17 | $14,059 | $3,874 | 27.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 37 | 37 | $12,223 | $3,717 | 30.4% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 20 | 20 | $12,180 | $1,932 | 15.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 23 | 23 | $4,492 | $991.59 | 22.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 135 | 206 | $6,180 | $640.66 | 10.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 21 | 21 | $2,667 | $522.69 | 19.6% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 20 | 20 | $1,840 | $467.40 | 25.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 49 | 54 | $4,536 | $412.34 | 9.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 83 | 104 | $2,080 | $228.80 | 11.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 22 | $352.00 | $184.80 | 52.5% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 29 | 30 | $6,330 | $156.60 | 2.5% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 21 | 44 | $1,279 | $96.54 | 7.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 134 | 166 | $87,316 | $25,411 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 177 | 238 | $38,080 | $21,747 | 57.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 126 | $15,120 | $8,386 | 55.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 63 | 64 | $21,504 | $6,740 | 31.3% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 26 | 26 | $19,786 | $6,447 | 32.6% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 36 | 36 | $21,924 | $5,588 | 25.5% |
About Dr. Bart Debrock, MD
Dr. Bart Debrock, MD is a Urology healthcare provider based in Vincennes, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1538155890.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bart Debrock, MD has received a total of $2,977 in payments from pharmaceutical and medical device companies, with $722.01 received in 2024. These payments were reported across 165 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,715).
As a Medicare-enrolled provider, Debrock has provided services to 4,468 Medicare beneficiaries, totaling 5,491 services with total Medicare billing of $388,999. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Vincennes, IN
- Active Since 09/22/2005
- Last Updated 03/21/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1538155890
Products in Payments
- XTANDI (Drug) $353.21
- ERLEADA (Drug) $277.41
- Erleada (Drug) $270.92
- UroLift (Device) $198.67
- Noctiva (Drug) $187.00
- SPEEDICATH (Device) $135.70
- GEMTESA (Drug) $117.29
- MYRBETRIQ (Drug) $109.08
- Xtandi (Drug) $108.74
- ALLODERM (Device) $90.37
- Bard Urinary Drainage Bag (Device) $89.98
- LUPRON DEPOT (Drug) $81.83
- ORGOVYX (Drug) $50.71
- Xofigo (Drug) $44.91
- JATENZO (Drug) $43.87
- Lupron Depot (Drug) $42.13
- UROLIFT (Device) $37.36
- PREMARIN (Drug) $33.47
- BMD-Bard Dimension (Device) $32.90
- Olympus Stents (Device) $29.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.